Adaptive Dose-Ranging Studies

[1]  S. Ruberg,et al.  Dose response studies. I. Some design considerations. , 1995, Journal of biopharmaceutical statistics.

[2]  Marc Vandemeulebroecke,et al.  Group Sequential and Adaptive Designs – A Review of Basic Concepts and Points of Discussion , 2008, Biometrical journal. Biometrische Zeitschrift.

[3]  Phase I Studies of Chemotherapeutic Agents in Cancer Patients: A Review of the Designs , 2006, Journal of biopharmaceutical statistics.

[4]  A. Genz,et al.  Computation of Multivariate Normal and t Probabilities , 2009 .

[5]  R. Kay.  Statistical Principles for Clinical Trials , 1998, The Journal of international medical research.

[6]  B. Turnbull,et al.  Group Sequential Methods with Applications to Clinical Trials , 1999 .

[7]  Andrew P Grieve,et al.  ASTIN: a Bayesian adaptive dose–response trial in acute stroke , 2005, Clinical trials.

[8]  B Klingenberg,et al.  Proof of concept and dose estimation with binary responses under model uncertainty , 2009, Statistics in medicine.

[9]  Frank Bretz,et al.  TUTORIAL IN BIOSTATISTICS Adaptive designs for confirmatory clinical trials , 2022 .

[10]  Holger Dette,et al.  Optimal Designs for Estimating the Interesting Part of a Dose-Effect Curve , 2007, Journal of biopharmaceutical statistics.

[11]  Frank Bretz,et al.  A Simulation Study to Compare New Adaptive Dose–Ranging Designs , 2010 .

[12]  Holger Dette,et al.  Optimal Designs for Dose-Finding Studies , 2008 .

[13]  Michael D. Smith,et al.  Adaptive Bayesian Designs for Dose-Ranging Drug Trials , 2002 .

[14]  Michael Krams,et al.  The past is the future: innovative designs in acute stroke therapy trials. , 2005, Stroke.

[15]  Anastasia Ivanova,et al.  Adaptive dose finding based on t‐statistic for dose–response trials , 2008, Statistics in medicine.

[16]  G. Navis,et al.  Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy? , 2005, Journal of the American Society of Nephrology : JASN.

[17]  David B Hall,et al.  A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials. , 2005, Contemporary clinical trials.

[18]  S. Ruberg.  Dose response studies. II. Analysis and interpretation. , 1995, Journal of biopharmaceutical statistics.

[19]  Frank Bretz,et al.  Comparison of Methods for the Computation of Multivariate t Probabilities , 2002 .

[20]  Christopher J Weir,et al.  Flexible Design and Efficient Implementation of Adaptive Dose-Finding Studies , 2007, Journal of biopharmaceutical statistics.

[21]  Y. Hochberg.  A sharper Bonferroni procedure for multiple tests of significance , 1988 .

[22]  L B Sheiner,et al.  Learning versus confirming in clinical drug development , 1997, Clinical pharmacology and therapeutics.

[23]  M. Krams,et al.  Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials , 2007, Journal of biopharmaceutical statistics.

[24]  J W Tukey,et al.  Testing the statistical certainty of a response to increasing doses of a drug. , 1985, Biometrics.

[25]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .

[26]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[27]  F Bretz,et al.  Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies , 2005, Biometrics.

[28]  Frank Bretz,et al.  Dose Finding – A Challenge in Statistics , 2008, Biometrical journal. Biometrische Zeitschrift.

[29]  Frank Bretz,et al.  MCPMod: An R Package for the Design and Analysis of Dose-Finding Studies , 2009 .

[30]  Sergei Leonov,et al.  An Adaptive Optimal Design for the E max Model and Its Application in Clinical Trials , 2009, Journal of biopharmaceutical statistics.

[31]  Paul Gallo,et al.  PhRMA Working Group on Adaptive Designs: Introduction to the Full White Paper , 2006 .

[32]  Gernot Wassmer,et al.  Adaptive Interim Analyses in Clinical Trials , 2010 .

[33]  John W. Tukey,et al.  Efficient Utilization of Non-Numerical Information in Quantitative Analysis General Theory and the Case of Simple Order , 1963 .

[34]  P. Westfall,et al.  Optimally weighted, fixed sequence and gatekeeper multiple testing procedures , 2001 .

[35]  Andrew P Grieve,et al.  Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): An Adaptive Dose-Response Study of UK-279,276 in Acute Ischemic Stroke , 2003, Stroke.

[36]  W. J. Studden,et al.  Theory Of Optimal Experiments , 1972 .

[37]  Y Hochberg,et al.  Multiple test procedures for dose finding. , 1996, Biometrics.

[38]  Joseph F. Heyse,et al.  An Empirical and Simulated Comparison of Some Tests for Detecting Progressiveness of Response with Increasing Doses of a Compound , 1992 .

[39]  F. Hsuan,et al.  Adaptive Designs for Dose-Finding Studies Based on Sigmoid E max Model , 2007, Journal of biopharmaceutical statistics.

[40]  Frank Bretz,et al.  Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations. White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Studies , 2010 .

[41]  Vladimir Dragalin,et al.  Adaptive Designs: Terminology and Classification , 2006 .